Security key
21833P301
Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (CRBP)
CUSIP: 21833P301
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock, $0.0001 par value
- Total 13F shares
- 10,752,925
- Total 13F value
- $486,116,698
- Share change
- +2,188,821
- Put/Call ratio
- 138%
- SEC-reported price per share
- $45.25
- Number of holders
- 107
- Value change
- +$101,256,908
- Number of buys
- 62
- Number of sells
- 38
- Shares outstanding
- 17,685,185
Holder snapshot
7 signals
Show 1 more signal
Security identity
1 source field
Report period
Q2 2024
Institutions
107
Top holders
10
CRBP full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Corbus Pharmaceuticals Holdings, Inc. SEC filings
Corbus Pharmaceuticals Holdings, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 21833P301
Recent filing periods:
Ownership snapshot
Top reported holders of CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Cormorant Asset Managemen...
Disclosed value leader
Cormorant Asset Managemen...
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F
Lead comparable stake: 11%
Showing 1-6 of 15 holder rows.
Quick read
Cormorant Asset Management, LP leads the comparable SEC ownership view at 11%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
Cormorant Asset Management, LP
11%
Point72 Asset Management, L.P.
4%
Ikarian Capital, LLC
3.2%
VANGUARD GROUP INC
2.5%
ADAGE CAPITAL PARTNERS GP, L.L.C.
2.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP |
13F
Company
|
11%
|
$79,461,000
2,025,000 shares
|
— | 31 Mar 2024 |
| Point72 Asset Management, L.P. |
13F
Company
|
4%
|
$27,530,666
701,597 shares
|
— | 31 Mar 2024 |
| Ikarian Capital, LLC |
13F
Company
|
3.2%
|
$21,945,794
559,271 shares
|
— | 31 Mar 2024 |
| VANGUARD GROUP INC |
13F
Company
|
2.5%
|
$17,158,239
437,264 shares
|
— | 31 Mar 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
2.3%
|
$16,284,600
415,000 shares
|
— | 31 Mar 2024 |
| Octagon Capital Advisors LP |
13F
Company
|
2.3%
|
$15,892,200
405,000 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
107
Shares
10,752,925
Rows available
107
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
81
Q2 2024 holders
107
Holder diff
26
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend